The emerging role of circular RNAs in drug resistance of non-small cell lung cancer

Tinghao Yan(Shandong University), Shulong Jiang(Jining First People's Hospital), Xinchen Tian(Jining First People's Hospital), Jianlin Wu(Shandong University of Traditional Chinese Medicine), Fen Liu(Lushan Botanical Garden), Qingbin Liu(Jilin Normal University)
Frontiers in Oncology
October 11, 2022
10.3389/fonc.2022.1003230
Cited by 10

Related Papers

Comprehensive profiling of lipid metabolic reprogramming expands precision medicine for HCC
|Hepatology|2024|60
Link of sorafenib resistance with the tumor microenvironment in hepatocellular carcinoma: Mechanistic insights
|Frontiers in Pharmacology|2022|53
Sinomenine inhibits A549 human lung cancer cell invasion by mediating the STAT3 signaling pathway
|Oncology Letters|2016|37
A comparative study on effects of dietary three strains of lactic acid bacteria on the growth performance, immune responses, disease resistance and intestinal microbiota of Pacific white shrimp, Penaeus vannamei
|Fish & Shellfish Immunology|2023|35
Lactate-mediated metabolic reprogramming of tumor-associated macrophages: implications for tumor progression and therapeutic potential
|Frontiers in Immunology|2025|32